• Activity INFORMATION

  Overview

  Globally, 1 in 5 patients are expected to develop heart failure at some point in their lives. With hospital readmission rates teetering around 50%, care for these patients is often complex and expensive. In recent years, sodium-glucose cotransporter-2 inhibitors (SGLT-2) have become a viable option for managing this patient population. This session seeks to compare and contrast the use of SGLT-2 inhibitors in heart failure with other available treatments, helping the practitioner identify patients who may most benefit from this therapy.
  

  Handouts

  • Slide Document :   22053H01_2pp.pdf Download

  • Slide Document :   22053H01_6pp.pdf Download

  Financial Support By

  PharmCon

• Learning OBJECTIVES

  Pharmacist

  Compare and contrast the benefits of SGLT-2 inhibitors compared to other available therapies for HFrEF and HFpEF

  Describe current treatment options for Heart Failure with reduced ejection fraction (HFrEF) and Heart Failure with preserved ejection fraction (HFpEF)

  Select optimal patient for initiating SGLT-2 inhibitors for treatment of heart failure

  Nurse

  Compare and contrast the benefits of SGLT-2 inhibitors compared to other available therapies for HFrEF and HFpEF

  Describe current treatment options for Heart Failure with reduced ejection fraction (HFrEF) and Heart Failure with preserved ejection fraction (HFpEF)

  Select optimal patient for initiating SGLT-2 inhibitors for treatment of heart failure

• Activity ACCREDITATION

  Activity Type

  Knowledge

  CE Broker

  20-916742

  Universal Activity Number

  Pharmacist 0798-0000-22-053-H01-P
  Nurse 0798-0000-22-053-H01-N
  

  PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

  PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

  In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

• Activity INSTRUCTION

  Faculty

  Kate  Moore, PharmD, BCPS, BCACP Clinical Pharmacist, Spartanburg Regional Healthcare System

This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).